Use of a new silver barrier dressing, ALLEVYN Ag in exuding chronic wounds.

Hdl Handle:
http://hdl.handle.net/10147/200986
Title:
Use of a new silver barrier dressing, ALLEVYN Ag in exuding chronic wounds.
Authors:
Kotz, Paula; Fisher, Jane; McCluskey, Pat; Hartwell, Samantha D; Dharma, Hussein
Affiliation:
E T Consultant Services Inc., Asheville, NC, USA.
Citation:
Use of a new silver barrier dressing, ALLEVYN Ag in exuding chronic wounds. 2009, 6 (3):186-94 Int Wound J
Journal:
International wound journal
Issue Date:
Jun-2009
URI:
http://hdl.handle.net/10147/200986
DOI:
10.1111/j.1742-481X.2009.00608.x
PubMed ID:
19538192
Additional Links:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737751/pdf/iwj0006-0186.pdf
Abstract:
Recognising and managing wounds at risk of infection is vital in wound management. ALLEVYN Ag dressings have been designed to manage exudate in chronic wounds that are at risk of infection; are displaying signs of local infection; or where a suspected increase in bacterial colonisation is delaying healing. They combine an absorbent silver sulfadiazine containing hydrocellular foam layer, with a perforated wound contact layer and highly breathable top film. The results presented are from a multi-centre clinical evaluation of 126 patients conducted to assess the performance of ALLEVYN Ag (Adhesive, Non Adhesive and Sacrum dressings) in a range of indications. Clinicians rated the dressings as acceptable for use in various wound types in 88% of patients. The majority of clinical signs of infection reduced between the initial and the final assessment. The condition of wound tissue and surrounding skin was observed to improve, and there was significant evidence of a reduction in the level of exudate from initial to final assessment (p < 0.001). Clinicians rated ALLEVYN Ag as satisfying or exceeding expectations in over 90% of patients. The evaluation showed the dressings to offer real benefits to patients and clinicians across multiple indications when used in conjunction with local protocols.
Item Type:
Article
Language:
en
Description:
Recognising and managing wounds at risk of infection is vital in wound management. ALLEVYN Ag dressings have been designed to manage exudate in chronic wounds that are at risk of infection; are displaying signs of local infection; or where a suspected increase in bacterial colonisation is delaying healing. They combine an absorbent silver sulfadiazine containing hydrocellular foam layer, with a perforated wound contact layer and highly breathable top film. The results presented are from a multi-centre clinical evaluation of 126 patients conducted to assess the performance of ALLEVYN Ag (Adhesive, Non Adhesive and Sacrum dressings) in a range of indications. Clinicians rated the dressings as acceptable for use in various wound types in 88% of patients. The majority of clinical signs of infection reduced between the initial and the final assessment. The condition of wound tissue and surrounding skin was observed to improve, and there was significant evidence of a reduction in the level of exudate from initial to final assessment (p < 0.001). Clinicians rated ALLEVYN Ag as satisfying or exceeding expectations in over 90% of patients. The evaluation showed the dressings to offer real benefits to patients and clinicians across multiple indications when used in conjunction with local protocols.
MeSH:
Adult; Aged; Anti-Infective Agents, Local; Bandages; Chronic Disease; Exudates and Transudates; Female; Humans; Polyurethanes; Silver Sulfadiazine; Treatment Outcome; Wound Infection
ISSN:
1742-481X

Full metadata record

DC FieldValue Language
dc.contributor.authorKotz, Paulaen
dc.contributor.authorFisher, Janeen
dc.contributor.authorMcCluskey, Paten
dc.contributor.authorHartwell, Samantha Den
dc.contributor.authorDharma, Husseinen
dc.date.accessioned2012-01-09T16:52:10Z-
dc.date.available2012-01-09T16:52:10Z-
dc.date.issued2009-06-
dc.identifier.citationUse of a new silver barrier dressing, ALLEVYN Ag in exuding chronic wounds. 2009, 6 (3):186-94 Int Wound Jen
dc.identifier.issn1742-481X-
dc.identifier.pmid19538192-
dc.identifier.doi10.1111/j.1742-481X.2009.00608.x-
dc.identifier.urihttp://hdl.handle.net/10147/200986-
dc.descriptionRecognising and managing wounds at risk of infection is vital in wound management. ALLEVYN Ag dressings have been designed to manage exudate in chronic wounds that are at risk of infection; are displaying signs of local infection; or where a suspected increase in bacterial colonisation is delaying healing. They combine an absorbent silver sulfadiazine containing hydrocellular foam layer, with a perforated wound contact layer and highly breathable top film. The results presented are from a multi-centre clinical evaluation of 126 patients conducted to assess the performance of ALLEVYN Ag (Adhesive, Non Adhesive and Sacrum dressings) in a range of indications. Clinicians rated the dressings as acceptable for use in various wound types in 88% of patients. The majority of clinical signs of infection reduced between the initial and the final assessment. The condition of wound tissue and surrounding skin was observed to improve, and there was significant evidence of a reduction in the level of exudate from initial to final assessment (p < 0.001). Clinicians rated ALLEVYN Ag as satisfying or exceeding expectations in over 90% of patients. The evaluation showed the dressings to offer real benefits to patients and clinicians across multiple indications when used in conjunction with local protocols.en
dc.description.abstractRecognising and managing wounds at risk of infection is vital in wound management. ALLEVYN Ag dressings have been designed to manage exudate in chronic wounds that are at risk of infection; are displaying signs of local infection; or where a suspected increase in bacterial colonisation is delaying healing. They combine an absorbent silver sulfadiazine containing hydrocellular foam layer, with a perforated wound contact layer and highly breathable top film. The results presented are from a multi-centre clinical evaluation of 126 patients conducted to assess the performance of ALLEVYN Ag (Adhesive, Non Adhesive and Sacrum dressings) in a range of indications. Clinicians rated the dressings as acceptable for use in various wound types in 88% of patients. The majority of clinical signs of infection reduced between the initial and the final assessment. The condition of wound tissue and surrounding skin was observed to improve, and there was significant evidence of a reduction in the level of exudate from initial to final assessment (p < 0.001). Clinicians rated ALLEVYN Ag as satisfying or exceeding expectations in over 90% of patients. The evaluation showed the dressings to offer real benefits to patients and clinicians across multiple indications when used in conjunction with local protocols.-
dc.language.isoenen
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737751/pdf/iwj0006-0186.pdfen
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshAnti-Infective Agents, Local-
dc.subject.meshBandages-
dc.subject.meshChronic Disease-
dc.subject.meshExudates and Transudates-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshPolyurethanes-
dc.subject.meshSilver Sulfadiazine-
dc.subject.meshTreatment Outcome-
dc.subject.meshWound Infection-
dc.titleUse of a new silver barrier dressing, ALLEVYN Ag in exuding chronic wounds.en
dc.typeArticleen
dc.contributor.departmentE T Consultant Services Inc., Asheville, NC, USA.en
dc.identifier.journalInternational wound journalen
dc.description.provinceMunster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.